CYNTHIA CARRION, AHMA president and Dr.
Robert Keller of US-based Keller Medical Institute partner to create the Asian
Regenerative Center for Cellular Therapies set to make the Philippines a hub
for regenerative cellular therapies in Asia
MANILA,
Philippines - The much-anticipated
opening of the Asian Regenerative Center for Cellular Therapies (ARCCT) will
soon be taking stem cell therapy treatment to a whole new level and on a larger
scale than ever before in the Philippines. Slated to open in September
2012,
the center will provide cellular regeneration therapies to treat conditions
related to aging and chronic pain.
The
ARCCT will be a pioneer and a leader in medical research and innovations,
immune and stem cell research and therapies, and in wellness and anti-aging
programs. The research and therapies of the ARCCT will serve to advance
knowledge of cellular regeneration medicine in Asia and the rest of the world.
Some of
the medical services and applications that the ARCCT will offer include immune
and stem cell storage; genetic tests; muscular dysfunction diseases (orthopedic
and reconstructive); chronic pain; antiaging therapies; organic vaccines; as
well as cosmetic and dermatologic treatments. “It is the ARCCT’s vision to
bring most advanced technology equipment available today for stem cell therapy
or regenerative cellular therapy.
This
technology and machinery has never been brought to the Philippines prior to the
ARCCT’s establishment,” said Cynthia Carrion, president of the Asian Holistic
Medical Alliance, which owns and administers the ARCCT in a joint venture with
the US-based Keller Medical Institute. Carrion is also the former Tourism
Undersecretary that helped launch the Philippines’ medical tourism program.
According
to Carrion, the ARCCT is envisioned to make the Philippines a hub for
regenerative cellular therapies in Asia. It will not only offer medical
treatments but also, just as importantly, the latest and best research on the
present and future applications of stem cell technology. “When it comes to
cellular regeneration therapy, the Philippines and the rest of the world have
yet to discover its full potential for improving human health.
The
kind of stem cell therapy that is being done in the Philippines today is just
the tip of the iceberg, so to speak. What the ARCCT will do is broaden the treatment
applications of stem cell or regenerative cellular therapies, and offer it on a
larger scale at more affordable prices. This will bring the benefits of
cellular regeneration therapy to more people,” said Carrion.
Carrion
added that the ARCCT’s wide range of applications for stem cell therapy offers
the chance for many patients to receive effective, non-surgical treatments for
many types of illnesses and conditions. “We would rather refer to stem cell
therapy as cellular regenerative therapy because of the wide range of
applications that this new medical technology can offer patients.
Also,
ARCCT will use stem cells that come from human sources, without using human or
animal embryos.
“You
see, stem cells can be sourced from bone marrow, cord blood, and even muscle,
skin
and adipose tissue. So if one has the proper technology, there’s really no need
to take from human or animal embryos,” she explained.
Some
conditions that cellular regeneration therapy is used for include the treatment
of autoimmune diseases; arthritis and cerebral palsy; diabetes type 2; heart
failure; multiple sclerosis; torn tendons, ligaments or muscles; stroke;
Parkinson’s disease; erectile dysfunction; hearing loss; muscular degeneration;
pulmonary fibrosis; emphysema; spinal cord injuries; lupus and certain viral
diseases.
Cellular
regeneration therapy may also be used in cosmetic, anti-aging procedures.
Another
interesting application of cellular regeneration technology is in the storage
of our immune cells.
By the
time a human being reaches the fifth decade of life, his or her immune cells
have grown old. This compromises a person’s immune system, reducing the body’s
capacity to fight diseases and the effects of old age. “Cellular regeneration
technology allows us to harvest immune cells, and to multiply and store them as
healthy immune cells.
These
healthy immune cells may be used on the patient to help fight various diseases,
including cancer and aging-related conditions,” said Carrion. The ARCCT is
established through a partnership between the Asian Holistic Medical Alliance
and the US-based Keller Medical Institute, a leading clinical facility for
cellular regeneration treatments that has already patented its own therapies
and procedures. The facility is composed of world-renowned physicians in
cellular regeneration medicine, including a Nobel Prize winner, under the
leadership of its CEO and medical director, Dr. Robert Keller.
Dr.
Keller’s expertise include non-surgical cosmetic treatments like lipolysis,
skin lasers, cosmetic injections, autologous fat transfer, as well as advanced
imaging and laboratory test analysis and wellness planning, as well as
predictive genetics. Dr. Keller also practices emergency medicine, family
clinical, urgent care clinical skills and sports medicine. He is also the CEO
and medical director of another clinic in the US, which is Regenertec, Inc.
The
cutting-edge technology that will be used by the ARCCT also makes it a
highly-advanced laboratory and diagnostics facility. For example, ARCCT
patients may avail of a genetic test that will map which diseases they are at
risk for, so they can take immediate steps to prevent those illnesses.
“Prevention
is a major component of the therapies that patients may avail of at the
ARCCT.Imagine, from just a simple saliva sample, the patient will already get
information on what diseases they are vulnerable to. In other words, why wait
until you get sick to get treatment? It’s much better to know what illnesses
you can prevent now, even before they occur,” said Carrion.
Those
who wish to take part in the next medical revolution and help the Philippines
make an impact in the world of medicine are invited to join the ARCCT.
Interested parties may send an e-mail to cnorton@skybroadband. com.ph. (Advt)
No comments:
Post a Comment